CCL Industries (CCL-B) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Jan, 2026Executive summary
Third quarter 2024 sales rose 9.4% year-over-year to $1,849.7 million, with 6.9% organic growth, 1.8% from acquisitions, and 0.7% from FX.
Operating income increased 13% to $288.9 million; net earnings for Q3 were $191.7 million, up from $169.1 million, and nine-month net earnings were $663.3 million, including a $78.1 million non-taxable revaluation gain.
Adjusted basic EPS for Q3 2024 was $1.09, up 14.7% from $0.95 in Q3 2023; nine-month adjusted EPS was $3.30, up from $2.79.
Free cash flow from operations was $233 million in Q3 and $618.6 million for the trailing 12 months.
All segments posted organic sales growth, with notable strength in Checkpoint (+14.5%) and Innovia (+18.0%).
Financial highlights
EBITDA for Q3 was $380.7 million, up 11% year-over-year; nine-month EBITDA rose 14% to $1,135.5 million.
Net debt increased to $1,675.8 million, mainly due to capex, acquisitions, and share buybacks; leverage ratio stood at 1.14x EBITDA.
Gross profit for Q3 was $551.3 million, up from $489.1 million in Q3 2023.
Free cash flow from operations for nine months was $344.8 million.
Strong liquidity with $759.6 million cash and $0.9 billion undrawn credit facility.
Outlook and guidance
Q4 faces higher hurdles due to tough comps and new plant startup costs, but October started better than expected.
CCL Secure expected to improve sequentially; Avery stable; Checkpoint RFID and Innovia recovery to continue.
CCL Design expected to slow as automotive industry softens.
FX expected to be a modest tailwind at current rates.
Latest events from CCL Industries
- Record 2025 sales, earnings, and cash flow drove higher shareholder returns and stable 2026 outlook.CCL-B
Q4 202526 Feb 2026 - Q2 2024 saw record sales, profit, and EPS, driven by organic growth and a major acquisition gain.CCL-B
Q2 20241 Feb 2026 - Q1 2025 saw record sales, earnings, and cash flow, with robust shareholder returns.CCL-B
Q1 20258 Jan 2026 - Record 2024 sales and earnings, strong cash flow, and positive but cautious 2025 outlook.CCL-B
Q4 20248 Jan 2026 - Q2 2025 saw record adjusted EPS, strong cash flow, and robust shareholder returns despite tariff headwinds.CCL-B
Q2 202523 Nov 2025 - Q3 sales and earnings rose, led by CCL and Checkpoint, with strong cash flow and $467.9M returned.CCL-B
Q3 202512 Nov 2025